Cargando…

Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort

BACKGROUND: Validated clinical prediction models to identify children with poor prognosis at the time of juvenile idiopathic arthritis (JIA) diagnosis would be very helpful for tailoring treatments, and avoiding under- or over-treatment. Our objective was to externally validate Nordic clinical predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Henrey, Andrew, Rypdal, Veronika, Rypdal, Martin, Loughin, Thomas, Nordal, Ellen, Guzman, Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964007/
https://www.ncbi.nlm.nih.gov/pubmed/31941530
http://dx.doi.org/10.1186/s13075-019-2091-8
_version_ 1783488412730261504
author Henrey, Andrew
Rypdal, Veronika
Rypdal, Martin
Loughin, Thomas
Nordal, Ellen
Guzman, Jaime
author_facet Henrey, Andrew
Rypdal, Veronika
Rypdal, Martin
Loughin, Thomas
Nordal, Ellen
Guzman, Jaime
author_sort Henrey, Andrew
collection PubMed
description BACKGROUND: Validated clinical prediction models to identify children with poor prognosis at the time of juvenile idiopathic arthritis (JIA) diagnosis would be very helpful for tailoring treatments, and avoiding under- or over-treatment. Our objective was to externally validate Nordic clinical prediction models in Canadian patients with JIA. METHODS: We used data from 513 subjects at the 3-year follow-up from the Research in Arthritis in Canadian Children emphasizing Outcomes (ReACCh-Out) cohort. The predicted outcomes were non-achievement of remission, severe disease course, and functional disability. The Nordic models were evaluated exactly as published and after fine-tuning the logistic regression coefficients using multiple data splits of the Canadian cohort. Missing data was handled with multiple imputation, and prediction ability was assessed with C-indices. C-index values > 0.7 were deemed to reflect helpful prediction. RESULTS: Overall, 81% of evaluable patients did not achieve remission off medications, 15% experienced a severe disease course, and 38% reported disability (CHAQ score > 0). The Nordic model for predicting non-achievement of remission had a C-index of 0.68 (95% CI 0.62–0.74), and 0.74 (0.67–0.80) after fine-tuning. For prediction of severe disease course, it had a C-index of 0.69 (0.61–0.78), and 0.79 (0.68–0.91) after fine-tuning. The fine-tuned Nordic model identified 85% of the cohort as low risk for a severe disease course (< 20% chance) and 7% as high risk (> 60% chance). The Nordic model to predict functional disability had a C-index of 0.57 (0.50–0.63), and 0.51 (0.39–0.63) after fine-tuning. CONCLUSIONS: Fine-tuned Nordic models, combining active joint count, physician global assessment of disease activity, morning stiffness, and ankle involvement, predicted well non-achievement of remission and severe disease course in Canadian patients with JIA. The Nordic model for predicting disability could not predict functional disability in Canadian patients.
format Online
Article
Text
id pubmed-6964007
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69640072020-01-22 Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort Henrey, Andrew Rypdal, Veronika Rypdal, Martin Loughin, Thomas Nordal, Ellen Guzman, Jaime Arthritis Res Ther Research Article BACKGROUND: Validated clinical prediction models to identify children with poor prognosis at the time of juvenile idiopathic arthritis (JIA) diagnosis would be very helpful for tailoring treatments, and avoiding under- or over-treatment. Our objective was to externally validate Nordic clinical prediction models in Canadian patients with JIA. METHODS: We used data from 513 subjects at the 3-year follow-up from the Research in Arthritis in Canadian Children emphasizing Outcomes (ReACCh-Out) cohort. The predicted outcomes were non-achievement of remission, severe disease course, and functional disability. The Nordic models were evaluated exactly as published and after fine-tuning the logistic regression coefficients using multiple data splits of the Canadian cohort. Missing data was handled with multiple imputation, and prediction ability was assessed with C-indices. C-index values > 0.7 were deemed to reflect helpful prediction. RESULTS: Overall, 81% of evaluable patients did not achieve remission off medications, 15% experienced a severe disease course, and 38% reported disability (CHAQ score > 0). The Nordic model for predicting non-achievement of remission had a C-index of 0.68 (95% CI 0.62–0.74), and 0.74 (0.67–0.80) after fine-tuning. For prediction of severe disease course, it had a C-index of 0.69 (0.61–0.78), and 0.79 (0.68–0.91) after fine-tuning. The fine-tuned Nordic model identified 85% of the cohort as low risk for a severe disease course (< 20% chance) and 7% as high risk (> 60% chance). The Nordic model to predict functional disability had a C-index of 0.57 (0.50–0.63), and 0.51 (0.39–0.63) after fine-tuning. CONCLUSIONS: Fine-tuned Nordic models, combining active joint count, physician global assessment of disease activity, morning stiffness, and ankle involvement, predicted well non-achievement of remission and severe disease course in Canadian patients with JIA. The Nordic model for predicting disability could not predict functional disability in Canadian patients. BioMed Central 2020-01-15 2020 /pmc/articles/PMC6964007/ /pubmed/31941530 http://dx.doi.org/10.1186/s13075-019-2091-8 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Henrey, Andrew
Rypdal, Veronika
Rypdal, Martin
Loughin, Thomas
Nordal, Ellen
Guzman, Jaime
Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort
title Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort
title_full Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort
title_fullStr Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort
title_full_unstemmed Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort
title_short Validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort
title_sort validation of prediction models of severe disease course and non-achievement of remission in juvenile idiopathic arthritis part 2: results of the nordic model in the canadian cohort
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964007/
https://www.ncbi.nlm.nih.gov/pubmed/31941530
http://dx.doi.org/10.1186/s13075-019-2091-8
work_keys_str_mv AT henreyandrew validationofpredictionmodelsofseverediseasecourseandnonachievementofremissioninjuvenileidiopathicarthritispart2resultsofthenordicmodelinthecanadiancohort
AT rypdalveronika validationofpredictionmodelsofseverediseasecourseandnonachievementofremissioninjuvenileidiopathicarthritispart2resultsofthenordicmodelinthecanadiancohort
AT rypdalmartin validationofpredictionmodelsofseverediseasecourseandnonachievementofremissioninjuvenileidiopathicarthritispart2resultsofthenordicmodelinthecanadiancohort
AT loughinthomas validationofpredictionmodelsofseverediseasecourseandnonachievementofremissioninjuvenileidiopathicarthritispart2resultsofthenordicmodelinthecanadiancohort
AT nordalellen validationofpredictionmodelsofseverediseasecourseandnonachievementofremissioninjuvenileidiopathicarthritispart2resultsofthenordicmodelinthecanadiancohort
AT guzmanjaime validationofpredictionmodelsofseverediseasecourseandnonachievementofremissioninjuvenileidiopathicarthritispart2resultsofthenordicmodelinthecanadiancohort
AT validationofpredictionmodelsofseverediseasecourseandnonachievementofremissioninjuvenileidiopathicarthritispart2resultsofthenordicmodelinthecanadiancohort